Nishinaga M, Shimada K
Department of Cardiology, Jichi Medical School, Tochigi-pref.
Rinsho Byori. 1994 Apr;42(4):340-5.
The endothelial surface plays an important role in the pathogenesis of atherosclerosis and the regulation of coagulation. It has become increasingly clear that while perturbed endothelial cells generate procoagulant activity, under normal conditions they possess multiple antithrombotic and anticoagulant mechanisms, including generation of prostacyclin and plasminogen activators and synthesis of thrombomodulin as a cell surface cofactor for thrombin-catalyzed activation of protein C. In addition, anticoagulantly active heparan sulfate proteoglycans, including heparin-like molecules are apparently present on the vascular surface. Previous studies showed that homocysteine, a thromboatherogenic and atherogenic agent, inhibits an endothelial thrombomodulin-protein C anticoagulant pathway. We examined whether homocysteine might affect another endothelial anticoagulant mechanism; i.e., heparin-like glycosaminoglycan-antithrombin III interactions. Incubations of cultured endothelial cells with homocysteine reduced the amount of antithrombin III bound to the cell surface in a dose- and time-dependent fashion. In contrast with a marked reduction in the maximal antithrombin III binding capacity, the radioactivity of [35S] sulfate incorporated into heparan sulfate on the cell surface was minimally reduced. Although neither net negative charge nor proportion in total glycosaminoglycans of cell surface heparan sulfate was altered by homocysteine treatment, a substantial reduction in antithrombin III binding capacity of heparan sulfate isolated from homocysteine-treated endothelial cells was found using both affinity chromatography and dot blot assay techniques. The antithrombin III binding activity of endothelial cells decreased after preincubation with homocysteine, cysteine, or 2-mercaptoethanol, containing a sulfhydryl group; no reduction in binding activity was observed after preincubation with methionine, alanine.(ABSTRACT TRUNCATED AT 250 WORDS)
内皮表面在动脉粥样硬化的发病机制及凝血调节中发挥着重要作用。越来越清楚的是,虽然内皮细胞功能紊乱会产生促凝活性,但在正常情况下它们拥有多种抗血栓形成和抗凝机制,包括生成前列环素和纤溶酶原激活剂,以及合成血栓调节蛋白作为凝血酶催化激活蛋白C的细胞表面辅助因子。此外,血管表面显然存在具有抗凝活性的硫酸乙酰肝素蛋白聚糖,包括类肝素分子。先前的研究表明,同型半胱氨酸作为一种促血栓形成和致动脉粥样硬化的因子,会抑制内皮血栓调节蛋白-蛋白C抗凝途径。我们研究了同型半胱氨酸是否可能影响另一种内皮抗凝机制,即类肝素糖胺聚糖-抗凝血酶III相互作用。用同型半胱氨酸孵育培养的内皮细胞,会以剂量和时间依赖的方式减少与细胞表面结合的抗凝血酶III的量。与最大抗凝血酶III结合能力的显著降低形成对比的是,掺入细胞表面硫酸乙酰肝素的[35S]硫酸盐的放射性仅有轻微降低。虽然同型半胱氨酸处理并未改变细胞表面硫酸乙酰肝素的净负电荷或其在总糖胺聚糖中的比例,但使用亲和层析和斑点印迹分析技术发现,从用同型半胱氨酸处理的内皮细胞中分离出的硫酸乙酰肝素的抗凝血酶III结合能力大幅降低。用含有巯基的同型半胱氨酸、半胱氨酸或2-巯基乙醇预孵育后,内皮细胞的抗凝血酶III结合活性降低;用蛋氨酸、丙氨酸预孵育后,未观察到结合活性降低。(摘要截短于250词)